Researchers at the Stanford University School of Medicine pinpointed why normal ageing is accompanied by a diminished ability to regain strength and mobility after muscle injury.
They said over time, stem cells within muscle tissues dedicated to repairing damage become less able to generate new muscle fibres and struggle to self-renew.
"In the past, it's been thought that muscle stem cells themselves don't change with age, and that any loss of function is primarily due to external factors in the cells' environment," said Helen Blau, a professor of microbiology and immunology and director of Stanford's Baxter Laboratory for Stem Cell Biology.
"Our findings identify a defect inherent to old muscle stem cells. Most exciting is that we also discovered a way to overcome the defect. As a result, we have a new therapeutic target that could one day be used to help elderly human patients repair muscle damage," she added.
More From This Section
The researchers found many muscle stem cells isolated from mice that were two years old, equivalent to about 80 years of human life, exhibited elevated levels of activity in a biological cascade called p38 MAP kinase pathway.
As a result, although many of the old stem cells divide in a dish, the resulting colonies are very small and do not contain many stem cells.
Using a drug to block this p38 MAP kinase pathway in old stem cells (while also growing them on a specialised matrix called hydrogel) allowed them to divide rapidly in the laboratory and make a large number of potent new stem cells that can robustly repair muscle damage, Blau said.
The researchers found that, when transplanted back into the animal, the treated stem cells migrate to their natural niches and provide a long-lasting stem cell reserve to contribute to repeated demands for muscle repair.
The research was published in journal Nature Medicine.